Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 10 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 4 institutions in 1 country.
Laura Gómez-JaramilloUnidad de Investigación, Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), 11009 Cádiz, Spain.
Fátima Cano-CanoUnidad de Investigación, Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), 11009 Cádiz, Spain.ORCID 0000-0002-7290-0812
Elena M Sánchez-FernándezDepartamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, 41012 Sevilla, Spain.ORCID 0000-0002-8617-8234
Carmen Ortiz MelletDepartamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, 41012 Sevilla, Spain.ORCID 0000-0002-7676-7721
José M García-FernándezInstituto de Investigaciones Químicas (IIQ), CSIC-Universidad de Sevilla, 41092 Sevilla, Spain.ORCID 0000-0002-6827-0387
Martín AlcaláDepartamento de Química y Bioquímica, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, 28668 Boadilla del Monte, Spain.ORCID 0000-0003-4678-8860
Fabiola Álvarez-GallegoDepartamento de Química y Bioquímica, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, 28668 Boadilla del Monte, Spain.
Marta IturreguiUnidad de Investigación, Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), 11009 Cádiz, Spain.
María Del Carmen González-MontelongoUnidad de Investigación, Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), 11009 Cádiz, Spain.ORCID 0000-0003-2332-6153
Antonio Campos-CaroUnidad de Investigación, Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), 11009 Cádiz, Spain.ORCID 0000-0001-8532-2153
Ana I ArrobaUnidad de Investigación, Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), 11009 Cádiz, Spain.ORCID 0000-0002-5136-1725
Manuel Aguilar-DiosdadoUnidad de Investigación, Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), 11009 Cádiz, Spain.
Universidad de Cádiz · ESUniversidad de Sevilla · ESUniversidad San Pablo CEU · ESInstituto de Investigaciones Químicas · ES
Funding
Consejería de Salud y Familias PI-0012-2019Consejería de Salud y Familias PI-0036-2020Consejeria de transformacion economica, industria, conocimiento y universidades PI-01331-2020Ministerio de Ciencia e Innovación PID2019-105858RB-I00Ministerio de Ciencia e Innovación PID2021-124247OB-C21Ministerio de Ciencia e Innovación RTI2018-097609-B-C21
6 · The paper itself
Abstract
Inflammatory processes play a central role in the pathogenesis of diabetic nephropathy (DN) in the early stages of the disease. The authors demonstrate that the glycolipid mimetic (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of ( · full record | OpenQuestion